Table 2 —

Characteristics of women with NGT and women with IGT paired on the basis of menopausal status, visceral AT area, and fat mass

Women with NGTWomen with IGT% Difference
n2727
Age (years)46.2 ± 11.145.4 ± 14.1–1.7
Menopausal (%)13 (48)13 (48)
Use of HRT* (%)5 (38)7 (54)
Body fat mass (kg)27.5 ± 8.827.6 ± 9.30.4
Visceral AT area (cm2)115 ± 40115 ± 380
Lipoprotein profile
 Cholesterol (mmol/l)
  Total5.03 ± 0.715.49 ± 0.849.1
  VLDL0.45 ± 0.320.60 ± 0.2933.3
  LDL3.29 ± 0.593.59 ± 0.799.1
  HDL1.28 ± 0.341.29 ± 0.270.8
  HDL20.52 ± 0.250.48 ± 0.18–7.7
  HDL30.72 ± 0.130.81 ± 0.1612.5
 Cholesterol/HDL-cholesterol4.12 ± 1.014.42 ± 1.167.3
 HDL2/HDL30.71 ± 0.290.61 ± 0.24–14.1
 Triglycerides (mmol/l)1.26 ± 0.651.96 ± 0.8047.6
 ApoB (g/l)0.96 ± 0.181.09 ± 0.2213.5
 ApoA-I (g/l)1.30 ± 0.161.39 ± 0.196.9
 LDL peak particle size (Å)253.9 ± 4.3253.1 ± 3.5–0.3
Insulin-glucose homeostasis
 Fasting glucose (mmol/l)4.92 ± 0.445.12 ± 0.424.1
 Fasting insulin (pmol/l)58.2 ± 31.781.9 ± 45.040.7
 Fasting C-peptide (pmol/l)754.3 ± 298.5854.8 ± 296.513.3
 Glucose area (× 10–3 mmol/l)1.15 ± 0.141.48 ± 0.15§28.7
 Insulin area (× 10–3 pmol/l)68.3 ± 28.5102.7 ± 51.650.4
 C-peptide area (× 10–3 pmol/l)533.8 ± 164.9626.2 ± 192.117.3
 2-h post-OGTT glucose (mmol/l)6.05 ± 0.858.76 ± 0.91§44.8
Blood pressure (mmHg)
 Systolic115 ± 12120 ± 204.3
 Diastolic¶74 ± 775 ± 91.4
  • Data are means ± SD.

  • *

    * Expressed as a percentage of menopausal women;

  • significantly different between women with NGT versus women with IGT, P < 0.05;

  • P < 0.005;

  • §

    § P < 0.0001;

  • n = 22 in women with NGT and n = 24 in women with IGT.